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ABSTRACT 
In an IT-enabled hybrid social startup, how and why does the social entrepreneur respond to conflicting 
commercial versus social norms and practices, as well as IT innovation challenges? We conducted an 
exploratory single-case study of an IT-enabled hybrid social startup consisting of a charitable pharmacy, 
two non-profit consortia, and two for-profit IT businesses, all co-founded by a pharmacist/social 
entrepreneur (with partners) who aimed to distribute donated “wasted” medications to needy patients. 
The two for-profit organizations were designing a blockchain and complementary web and mobile 
applications for secure, cost-effective donated-drug distribution, for use by this entrepreneur’s charitable 
pharmacy and other organizations committed to matching donors with needy patients. Study findings 
suggests that multiple forms of IT agility, multiple forms of business agility, and a unique form of social-
commercial agility help an IT-enabled hybrid social startup persist, despite financial and other challenges. 
Keywords (Required) 
IT innovation, social entrepreneurship, blockchain, social enterprise, startup 
Introduction  
Like a commercial startup, a social startup adjusts strategic, structural and operational elements along the 
road to financial viability (Dacin et al. 2011). Prior studies report social entrepreneurs confront competing 
commercial and social demands (Dees 1998; Austin et al., 2006; Bacq & Janssen 2011). How do they 
respond to IT innovation challenges in this context? I present initial findings from an exploratory single-
case study of an IT-enabled hybrid social startup consisting of a charitable pharmacy, two non-profit 
consortia, and two for-profit startup IT businesses. With partners, a social entrepreneur founded these 
organizations in order to cost-effectively distribute donated medications to needy patients. To that end, 
the two for-profit organizations were designing and intended to build a blockchain and complementary 
web-based and mobile applications, for use by this charitable pharmacy and other organizations seeking 
to efficiently and securely deliver donated medications to authorized patients.  
The paper contributes to a small stream of studies of IT-enabled hybrid social enterprises. While a robust 
stream of research has focused on IT-enabled entrepreneurship, few studies have focused on IT-enabled 
social entrepreneurship, particularly at the startup phase. 
Social Enterprise and Social Entrepreneurship 
Social entrepreneurship “solves social problems using market-based methods” (Hota et al. 2019, p. 1). 
Addressing how non-profit, governmental or for-profit organizations engage in societally-beneficial 
activities (Austin et al. 2006), social entrepreneurship emerged as a distinct field around 2005. A “social 
enterprise” is an organization that “applies the entrepreneurial practices of business to the pursuit of 
opportunities for social value creation and social transformation, rather than for traditional profit 
maximization” (Richardson et al. 2014).   
 
“Social entrepreneurship” and “social enterprise” cover a spectrum of non-commercial and commercial 
activities (Dees 1998). (Table 1, below). When traditional non-profits launch commercial activities, “often-
perilous currents of commercialization … must be navigated with care” (Dees 1998, p. 7).  “Perils” include 
perceived conflicts between new revenue sources and social mission, difficult development of new 
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capabilities and processes, core constituents’ skepticism/distrust, and for-profit competitors (Dees 1998). 
Studies examined various organizations (large/small, longstanding/startup), stakeholders (beneficiaries, 
funders, employees, suppliers), and strategic, financial, ethical and other challenges (Short et al. 2009). 
 
 
Purely 
Philanthropic 
 
 
Purely 
Commercial 
Motives 
Methods 
Goals 
Appeal to goodwill 
Mission driven 
Social value 
Mixed motives 
Mission and market driven 
Social and economic value 
Appeal to self-interest 
Market driven 
Economic value 
Table 1. Social Enterprise Spectrum (Adapted from Dees 1998) 
 
The tipping point for the social entrepreneurship field (point when publications accelerated, after a long 
lead-in) was 2005 (Hota et al. 2019). Table 2 summarizes its evolution since then. 
 
Before 2006 2006 onwards 2010 onwards 2017 onwards 
Social entrepreneur 
Social entrepreneurship 
Social enterprise 
Social entrepreneurship 
Hybrid social enterprise 
Social entrepreneurship 
Ethical social enterprise 
Hybrid social enterprise 
Table 2. Evolution of Social Entrepreneurship Research (Adapted from Hota, et al. 2019) 
At least 16 literature reviews were published since 2005 (Hota et al. 2019). Studies cover four contexts: 
startup social enterprises, traditional non-profits that launch commercial enterprises, government 
agencies that launch commercial enterprises, and traditional for-profits that offer socially-responsible 
products and services (critics argue development of a strong theoretical foundation has been impeded by 
over-broad definitions (Dacin, et al. 2011), such as inclusion of CSR studies; Choi & Majumdar 2014).   
Our case study examines the journey of a social entrepreneur who established a charitable pharmacy, then 
founded two non-profit consortia and two for-profit startup IT businesses to achieve his social aims. 
Together (how he viewed them) the five organizations constitute one hybrid social enterprise.   
Social Entrepreneurship Challenges 
Social entrepreneurs encounter challenges related to combining social and commercial goals and 
operations. When traditional nonprofits introduce commercial activities in their social programs, some 
stakeholders respond with skepticism and distrust (Dees 1998) – especially when leaders replace 
emotionally-sticky traditions with commercial ones (Austin et al. 2006, p. 12).  Conflicting behavioral 
norms may play out in several ways. For example, rapid business-like growth is hard on organizations 
accustomed to a slower cadence of work (Austin et al. 2006). Many nonprofit leaders, lacking business 
training, experience difficulty acquiring necessary knowledge and building new capabilities (Dees 1998).  
Researchers are encouraged to further study how various challenges are effectively managed – such as by 
investigating whether/how governance structures help (Bacq & Janssen 2011). One theory proposes 
successful social entrepreneurs manage with compassion, which is theorized to be a prosocial motivator 
that influences three cognitive/affective processes -- integrative thinking, cost-benefit analysis, 
commitment to a higher social cause – which in turn help leaders resolve tension and find acceptable 
paths to their social aims (Miller et al. 2012). “Because social businesses represent an intermingling of 
traditional values associated with both for-profit and non-profit activity within the same enterprises, 
they join concepts traditionally held as contradictory … The marriage of antithetical ideas … leads to a 
different way of doing business.”  (Wilson & Post 2013, p. 716 and p. 730; see also Mair & Schoen 2007).  
In contrast to this optimistic view, other studies report that competing tensions bring problems. An 
ethnographic study in England reported that social enterprises constantly negotiate “between diverse and 
competing goals, motivations and commitments” (Mazzei 2017 p. 304), which impede development of 
consistent and efficient operations. Inefficiency intensifies the pressure, which led organizations to focus 
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on constituents they could most easily serve, not those in greatest need. Tensions spiraled ever-faster, as 
these nonprofits came under fire for neglecting their core missions.  
Hybrid social enterprises confront complex challenges in three broad areas: revenue-generating tactics, 
professionalizing the organization, legitimating a new business model (Ko & Liu 2020). Yet, few prior 
studies focused on how NPOs transform into hybrid social enterprises, and further research is thus 
needed on how and why challenges arise and are resolved during this transformation (Ko & Liu 2020). 
To summarize: Prior social entrepreneurship research reveals four main challenges related to: 1) 
development of business knowledge, skills and capabilities; 2) conflict between commercial and social 
norms/objectives; 3) conflict between business and social practices; 4) stakeholder distrust/skepticism. 
 
ICT for Good: ICT4D, Frugal IS Innovation, BoP, CSR 
Among many studies of IS innovation and IT-focused entrepreneurship, few investigated IT-enabled 
social entrepreneurship or IT-enabled hybrid social enterprises. An extensive review of almost 300 papers 
(Steininger 2019) in 18 prominent journals (8 AIS Senior Scholars Basket, 4 top Entrepreneurship 
journals, 6 other prominent journals), just one dealt with IT-enabled social enterprise; a case study of the 
Cure4Kids pediatric cancer social networking platform hosted by St. Jude’s Children’s Hospital 
(Richardson et al. 2014).  That study revealed that 1) St. Jude’s open access philosophy attracted helpful 
collaborators; 2) use of open source tools kept costs low; 3) a “simple and adaptable” platform was 
designed for flexibility and adaptability, and the Cure4Kids initiative demonstrated customer agility, 
partnering agility and operational agility (dimensions proposed by Sambamurthy 2003).  
With one social enterprise study revealed in Steininger’s review (2019), we searched for relevant research 
in studies of ICT4D, Frugal IT Innovation, Bottom-of-the Pyramid, and CSR.  
 
Many ICT4D projects fail. One proposed reason: four (or more) differing views of “development” aims 
lead different constituents to apply different ICT4D project evaluation criteria. Stakeholders who 
subscribe to a development goal of “freedom” or “wellbeing” (for example) may show disinterest in an 
innovation designed with “inclusion” or “economic productivity” as the aim (Chipidza and Leidner 2019).  
The Frugal IT perspective extends the notion of entrepreneurial bricolage (“making do with what is at 
hand,” per Baker & Nelson 2005), by noting that declining costs and improving performance of hardware 
and software technologies enable creation of cost-effective yet sophisticated IT innovations. Frugal IT 
studies intersect with ICT4D when they investigate provision of low-cost IT-enabled products and services 
in underserved sectors. A case study of a social network (Okwaho Network) for indigenous peoples of 
North America concluded that a Frugal IT Innovation Capability combines three types of innovation: 1) 
business innovation 2) IT innovation, 3) social innovation (Ahuja and Chan 2016).  
Bottom-of-the-pyramid (BoP) research focuses on products and services designed for extremely 
impoverished customers. BoP marketers confront financial, spatial, temporal and information challenges 
(Tarafdar et al, 2013). Implementation of a community weather station in Africa demonstrated frugal IT 
deployment for a BoP shared-good infrastructure (Howell et al. 2018). BoP researchers are advised to 
study questions such as: Do business ecosystems (continuously collaborating multiple actors) contribute 
to BoP success? What revenue models are effective in BoP contexts? After conducting pilot tests, how do 
successful BoP initiatives scale up? 4) Are business model innovation and business process innovation 
necessary? 5) How do viable BoP initiatives involve their constituents? (Joncourt et al. 2019). 
 
IT-related corporate social responsibility (CSR) initiatives aim to strengthen an organization’s  image or 
brand, develop and test innovations (Kanter 1999), provide  technical skills training  to increase this labor 
pool (Porter & Kramer 2007), and for other reasons. A case study of IT work outsourced to a poor Indian 
community revealed benefits and challenges for employees and the local community (Madon & 
Sharanappa 2013), and a case study of American outsourcer Liberty Sourcing revealed that IT-related 
CSR initiatives may apply commercial and social logics at different times.  (Khan et al. 2018). 
 
To summarize: Prior “IT for Good” studies (in ICT4D, Frugal IT, BoP and CSR research streams) propose 
that successful social innovation projects exhibit IT agility through open collaboration, use of open source 
tools, and building or acquiring a simple, adaptable IT platform. They exhibit business agility through 
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innovative business models, partnering/relational agility, and operational agility (e.g, process innovation, 
cost control), and they selectively apply commercial and social logics over time.  
 
Research Method 
We sought to conduct an exploratory study to answer the following overarching question: How and why 
does the leader of an IT-Enabled Hybrid Social Startup respond to challenges (e.g., knowledge/skill 
acquisition, commercial versus social norms and practices, stakeholder skepticism/distrust)? More 
specifically, in an IT-enabled hybrid social startup …   
 
RQ1 Which challenges/tensions are related to development of IT knowledge and capabilities? 
 
RQ2  Does the social startup exhibit IT agility through open collaboration, use of open source code, use 
of a simple and adaptable platform, and/or other forms of IT agility? 
 
RQ3 Does the social startup exhibit business agility through an innovative business model innovation, 
partnering/relational agility, operational agility, and/or other forms of business agility? 
 
RQ4 Does the social entrepreneur selectively apply commercial and social logics? 
A single-case study is an appropriate method for exploring “how and why” questions (Yin 2014, p. 29), 
especially in longitudinal studies (Yin 2014, p. 53). This case study, of a blockchain initiative for 
medication waste redistribution, was part of a larger research program on IT Innovation in Health Care.   
Blockchain is on Gartner’s Strategic Technology list (Cearley et al. 2017; Gartner 2019), and it is predicted 
that blockchain will not have widespread transformative impact in health care before 2029 (Blosch 2019). 
Thus blockchain is an early-stage IS innovation in health care.  
In the AIS Scholars Basket of eight prominent IS journals, we found no studies of blockchain-based social 
entrepreneurship in health care. A call for research on blockchain-enabled supply-chains saw their value 
for health care (Treiblmaier 2018). Practitioner publications emphasized blockchain as a high-potential 
technology in healthcare (Peterson et al. 2016; Halamka et al. 2017; Pirtle & Ehrenfield 2018; Ribitzky et 
al. 2018) and in pharmaceutical companies’ supply chains (Blossey, et al. 2019; Felin & Lakhani 2018; 
Iansiti & Lakhani 2017; Lacity 2018; Nash 2018; Zahreddine 2018; Zhang et al. 2018). 
With early-stage blockchain efforts underway in pharmaceutical supply chains, we sought a case site 
where we could focus on a social entrepreneur during early stages of an IT-enabled hybrid social startup. 
In early stages, the entrepreneur is the face of the organization, through interaction with the broader 
community and industry context. As a startup matures, norms develop and practices become routinized. 
At that point, much can be learned by observing work practices and capturing the perspectives of actors in 
many roles (we hope to conduct such a study when this initiative reaches that next stage.). 
At a fall 2018 Blockchain in Healthcare conference sponsored by ConsenSys Health, one author attended 
a talk by “Dr. Block” (disguised) about a new “DrugsBlock” (disguised) initiative he was leading. We 
subsequently obtained permission to conduct a longitudinal case study of DrugsBlock.  Data was obtained 
from the following sources: 
 Face-to-Face interview with Dr. Block at the fall 2018 conference. 
Observation (recorded):  
1. 120 minutes: Dr. Block and associates presentation at a Feb 2019 IEEE Working group meeting. 
Telephone interviews (recorded using Zoom): 
1. 90 minute second interview with Dr. Block in winter 2019 
2. 70 minute third interview with Dr. Block in spring 2019 
3. 60 minute interview with the Director of Customer Service in spring 2019 
4. 90 minute interview with the family member of a deceased cancer patient, whose leftover 
medications were donated to Dr. Block’s organization in summer 2019 
5. Emails and short phone calls with Dr. Block in summer and fall 2019 and winter 2020. 
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Beyond factual questions (who/what/when) our interviews were conducted in a conversational open-
ended style, so as to initially capture interviewees’ unprompted thoughts about successes and challenges, 
and follow through with focused prompts, as appropriate. 
 
Other Sources: 
To triangulate on the case timeline and other facts, we developed an extensive archive of news accounts, 
blogs, and other primary and secondary sources reporting on the DrugsBlock initiative.  
 
We drew on all of these sources to develop an accurate retroactive account of this social entrepreneur’s 
journey from 2015 through 2017 and to chronicle his journey as it continued to unfold in 2018 and 2019.  
 
The first product of this case study was a teaching case, prepared after the completion of factual coding 
(“anchor date” is May 2019).  In follow-up phone calls and emails during development of that case, 
interviewees clarified case facts. Dr. Block reviewed several drafts, each time clarifying and sometimes 
describing unfolding new developments.  
Interviews were transcribed using Zoom’s closed captioning feature; transcripts were subsequently edited 
to correct transcription errors. Coding was done in winter, spring, summer and fall 2019: 
 Factual coding supported creation of a timeline and map of actors to events. 
 In several other rounds of factual and interpretive coding conducted in 2020, we noted evidence 
pertaining to our research questions. 
 
Case Overview 
Dr. Block’s hybrid social enterprise journey reveals key challenges he encountered. Dr. Block, a licensed 
pharmacist and former member of the U.S. Marine Corps, worked in a poor neighborhood in one of the 15 
poorest U.S. states (therefore, a BoP context).  In 2013 he began considering how to help needy patients 
get affordable medications. In the first decade of his pharmacist career he saw many patients who, due to 
affordability issues, cut pills in half, skipped doses, or failed to pick up prescribed drugs -- actions that 
sometimes led to severe health issues. New cancer drugs were especially expensive.  
In 2015 Dr. Block resigned his pharmacy post and (with a partner) launched a 501(c) (3) charitable 
pharmacy, “Charmacy” (disguised). He learned how to obtain affordable drugs from charitable 
wholesalers (which collect donated drugs from pharma companies) and “wasted” drugs from nursing 
homes and hospitals (“wasted” when a patient recovers, discontinues because of an adverse reaction, or 
dies). To raise money for Charmacy from his church and other sources, Dr. Block gave presentations 
describing heart-wrenching vignettes about patients struggling to afford medications.  
Charmacy was set up as a membership service. Many members paid less than the posted $600 annual 
membership fee, based on a sliding “ability-to-pay” scale. Some drugs were free, others were provided at 
wholesale cost. Skeptics questioned whether a membership model was appropriate; paying for member-
ship plus at-cost purchases, would patients actually save money? Chronically ill patients could save a great 
deal, but critics warned that other patients might, in a given year, spend more than before (similar to 
critics of BJ’s, Costco, or Sam’s Club). However, patients were permitted to join or terminate membership 
at any time. This created financial uncertainty for the pharmacy, and as of winter 2020, membership fees 
and discounted sales did not generate enough revenue to fully offset operational costs. 
Most states do not permit individual patients/families to donate wasted drugs. In 2016 Dr. Block 
successfully lobbied for a new law to permit charitable pharmacies to accept individually-donated wasted 
medications in his state. Once it passed, he hoped individually-donated medications would help reduce 
Charmacy operating costs. After the law’s passage, it took two years for various agencies to finalize rules.  
Meanwhile, Dr. Block moved forward on several fronts. He co-founded a consortium of charitable U.S. 
pharmacies, to serve as an information source and catalyst for change. He attended conferences and 
workshops to learn about IT in health care. In 2017 he began to focus on potential blockchain solutions in 
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pharmaceutical supply chains. He invited various people he met at conferences or in his community to 
participate in a series of informal conference calls about how blockchains could support the processes of 
receiving donated medications, authenticating them, and redispensing them to needy patients. Soon, at 
conferences he was giving talks to persuade others that blockchains could be deployed in these contexts. 
Next, Dr. Block founded two for-profit Limited Liability Corporations (LLCs) to develop software for sale 
or rent to other organizations. DrugsBlock LLC (disguised) was co-founded with the CEO of a small 
private software company. In summer 2018 this LLC launched a website to solicit medication donations 
and gather patient requests for medications. In one month, Dr. Block and his partner felt it generated 
enough offers and requests to prove the concept with Charmacy. Next, a team was formed to design and 
build a blockchain. Dr. Block requested that any software built by this company should be designed for 
maximum scalability and adaptability. He envisioned a “platform” consisting of blockchain tools and code 
that could be monetized for sale or rent to other organizations’ medication-donation services. A second 
LLC, co-founded with a local entrepreneur, built an Uber-like mobile app to support volunteers willing to 
drive donated drugs to authorized patients, and planned to design a compatible blockchain to support 
secure delivery of authorized wasted prescriptions to authorized patients. Dr. Block again hoped this 
software would use a common platform for scalability and adaptability, and that it could be sold or rented 
to other charitable organizations (engaged in medication redistribution or just needing to track volunteers 
who would drive patients to appointments, deploy voluntary responders in crises, etc.).  
In winter 2019 DrugsBlock LLC joined a national consortium that planned to pilot-test a variety of 
blockchain applications in the pharmaceuticals supply chain. Dr. Block also established a new consortium 
that would focus on redistribution of wasted medications. He reached out to pharmacy schools, hospital 
and clinic pharmacies, and prescribers, who he hoped would help develop new solutions and test the 
DrugsBlock blockchain (by serving as nodes on it, once built).  A few local organizations as well as one 
distant U.S. partner and one international partner joined this consortium by January 2020 (founding 
members paid a modest $5000 consortium membership fee).  
In 2019 some non-blockchain pilot tests of essential applications and processes were conducted, and in 
2020 Dr. Block and a colleague continued to reach out to potential local partners and others whose vision 
was national or international in scope. The blockchains were still in the design stage, but he hoped by 
year-end 2020 a scalable secure chain-of-custody system for authenticating, dispensing and delivering 
donated drugs to authorized patients would be launched by DrugsBlock LLC and the other LLC. Dr. Block 
hoped both LLCs would soon attract venture funding. 
Findings Mapped to Research Questions 
RQ1 Which challenges/tensions are related to IT knowledge and capabilities? 
 
Dr. Block expressed considerable IT-related frustration. Having read about agile software development, 
he expected a blockchain development team would work in a “fail-forward” way (create and test many 
prototypes, release a minimally-viable product for more extensive testing. He came to understand (at a 
high level) why a blockchain in this context needs an extensive design phase to avoid problematic changes 
later on. The technical issue is that when changes create “hard forks” in a blockchain, it can quickly 
become very unwieldy. A path forward is to focus on well-specified modular use-cases that translate into a 
series of fairly simple blockchains that can subsequently be linked together into an end-to-end system. 
Precise specification of modular use-cases requires extensive domain knowledge and thorough analysis. 
As of January 2020, Dr. Block had not yet fully come to terms with this challenge; he vacillated between 
optimism and frustration.  Since several times he mentioned the hope that his organizations would soon 
attract venture capital, we believe his frustration stems from the realization that until the team develops a 
minimally viable blockchain solution, VCs will remain on the sidelines. He might have come to 
understand that the design teams’ slow pace is fairly typical for a blockchain initiative in an inter-
organizational context such as a supply chain. Progress is likely also hampered by talent and funding 
constraints, but only the latter concerns him at this point. 
Dr. Block moved forward rapidly on other IT initiatives. For example: unhappy with the first version of 
the DrugsBlock website, he oversaw a redesign (and produced some of the new code); it was launched in 
early 2020. He also oversaw development and launch of a minimally-viable mobile application to 
automate much of the data-capture that is necessary when medications are donated.  
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RQ2  Does the hybrid IT-enabled social startup exhibit IT agility through open 
collaboration, use of open source code, use of a simple and adaptable platform, 
and/or other forms of IT agility? 
 
Dr. Block’s hybrid social startup exhibits an open collaboration approach – he gathered information by 
attending conferences and inviting people to brainstorm about blockchain for medication redistribution. 
He and colleagues presented their ideas for a donated-drugs blockchain at IEEE workshops and other 
forums. The team chose the Ethereum platform for testing elements of the design (use of open-source 
code), and Dr. Block asked his team to design a scalable and adaptable system that could be offered (to 
Charmacy and others) as a “platform” (his word choice) that could support similar initiatives.  
Dr. Block did not use the word “agile.” He did mention the acronym MVP (minimally viable product) and 
described a “fail-forward” philosophy – both of which are consistent with agility. He discovered a latent 
aptitude for developing applications (or at least, minimally-viable applications). Yet, we see risk in his 
embrace of IT agility, because we suspect he might have more confidence than is warranted by his current 
level of IT skill and knowledge. A hands-on manager, he will likely need to take his hands off the code as it 
is modified for interoperability and compliance with existing regulations and healthcare standards. 
RQ3 Does the hybrid IT-enabled social startup exhibit business agility through 
an innovative business model, customer and/or partnering agility, operational 
agility, and/or other forms of business agility? 
 
Dr. Block is energetic, persuasive, upbeat, action-oriented. In less than five years he cofounded five small 
organizations, presented at many conferences, built an extensive network of collaborators from whom he 
learned about many business and IT practices, and participated in another consortium’s pilot testing. He 
is a tireless promoter whose actions suggest a deeply-rooted belief that it is better to “do something” and 
learn fast (i.e., be agile) than to plan thoroughly and learn slowly. His world view is similar to many 
entrepreneurs (both successful and unsuccessful ones).  
The Charmacy membership model and its direct-fulfillment model (no retail presence) is an innovative 
business model, and at one point he attempted to sell a sort of private-label pharmacy-benefit service to 
help small businesses reduce their medication-benefit costs (that initiative was subsequently shelved). Dr. 
Block’s decision to lobby for passage of a new law opened the door to allow it to re-dispense individually-
donated drugs -- another innovative business model. The other LLC ‘s ride-sharing model is an innovative 
adaptation of an Uber-like business model, in the service of a social mission. Further evidence of business 
model agility may emerge as both social businesses mature.  
Dr. Block developed a growing network of useful associates– some young and ambitious, others older and 
well known. Some focus on blockchains; others focus on serving needy patients. He has allied with useful 
partners and recruited small teams of people to join his organizations full time or part time (apparently 
offsetting low monetary compensation with shares in his LLCs).  
Like many entrepreneurs, he constantly questions the status quo and launches small-scale experiments –. 
For example, a decision to shift to dispensing all ongoing chronic-disease prescriptions on a quarterly 
basis will reduce 2020 operational costs. Dr. Block also believes that in 2020, individually-donated 
medications will both help drive down pharmacy costs and attract new members.  
Although Dr. Block embraces the agile philosophy of experimenting and learning, he has not yet learned 
how to carefully design experiments for optimal insight, and he appears to rely heavily on intuition rather 
than analysis. For example, the website that was set up to solicit donations and requests for medications 
did not capture sufficient information to accurately estimate granular patient demand and donor supply.  
RQ4 Does the social entrepreneur selectively apply commercial and social logics? 
Dr. Block either chooses not to dwell on social-business tension, or actually experiences little such 
tension. He does seem to selectively apply commercial and social logics at different times and in different 
situations, in a nearly-seamless manner.  
In the chronology recounted above, this IT-focused social entrepreneur initially focused on local 
opportunities and locally-focused organizations. He did volunteer medication consultations with 
parishioners, launched a charitable pharmacy, and helped to pass the state law that now allows 
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individuals to donate wasted drugs to charitable pharmacies. Yet, his vision scaled quickly and 
expansively, leading him to found the national consortium of charitable pharmacies and a consortium of 
health-care providers and institutions that he hopes will scale locally, nationally, and internationally. He 
also participating in pilot tests conducted by another (much larger) consortium.  
Like many successful commercial entrepreneurs, Dr. Block is a gifted communicator and natural 
networker. He recounts compelling patient and family stories, interleaved with facts about high drug 
prices and usable medications that could reach needy patients. Is this evidence of compassion as a 
prosocial motivator (Miller 2013; Wilson & Post 2014) or merely a clever sales pitch? We cannot say. This 
visionary IT-focused social entrepreneur’s talks are sometimes ahead of the facts. For example, since 
founding DrugsBlock LLC in summer 2018, in numerous presentations and other venues Dr. Block 
described it as a “blockchain company.” Although design was underway and a few demonstration 
prototypes developed no operational blockchain had been launched by the end of 2019. 
Possibly anticipating skepticism about Charmacy’s business model, Dr. Block offered an ability-to-pay 
sliding scale membership fee. He also anticipated potential skepticism if the blockchain only supported 
donations of expensive cancer drugs (versus high-volume inexpensive wasted drugs (he stated a concern 
that people might think he was “chasing the money”). He simultaneously considered multiple factors - 
logistics, sustainability, constituents he could most easily serve versus those in greatest need. He was 
preoccupied with finding a path to financial viability for Charmacy and profitability for DrugsBlock LLC 
and the other LLC, but otherwise he expressed little concern about conflicting social and business norms.  
Each organization was set up appropriately from a legal and risk-management perspective, yet Dr. Block’s 
comments (such as referring to Charmacy as a “sister organization”) imply he thought of them as one 
collective organization (a hybrid social enterprise). Sometimes when he mentioned “DrugsBlock” we came 
to realize (to our consternation!) that he was really talking about Charmacy or the other LLC or the local 
consortium. Sometimes a mention of “Charmacy” referred to something occurring at DrugsBlock. Thus, 
when speaking with interviewers and journalists about his work, it was with reference to the hybrid social 
enterprise as if it was a single entity.  Yet, when he gave presentations to potential donors or potential 
investors, he put on the social or commercial “hat” that matched the audience, with (as best we can tell) 
no evident discomfort in switching perspectives from one to the other. 
 
Conclusion 
Consistent with prior studies, Dr. Block confronted and overcame many challenges. Before becoming a 
social entrepreneur he developed some business capabilities in his ten years as a pharmacist, and he took 
the initiative to learn how charitable pharmacies and charitable pharmacy wholesalers work.  Recognizing 
the problem of usable medication waste, he researched drug donation laws in other states (e.g., Iowa, 
California) and successfully lobbied for a new law in his state. He invented a new business model for the 
charitable pharmacy he co-founded, and refined it over time (such as by developing its capability to accept 
and authenticate donated “wasted” medications, and redispense them for delivery to needy patients. 
Seeing an opportunity to profit by building a blockchain-based platform that could support other charity 
pharmacies or other organizations in the pharmaceutical supply chain, he co-founded two for-profit 
startups for that hybrid social purpose, as well as two consortia for promoting information-sharing and 
other forms of helpful collaboration in this space.  
Given that this hybrid social enterprise is currently still in a startup phase, it is too early to proclaim 
“success” – it has not achieved its social mission in any meaningful way -- thus far, but a handful of 
patients have received donated medicines, and neither of the two for-profit organizations has, as yet, 
attracted venture capital (nor have they, as yet, failed). Clearly none of the five organizations co-founded 
by Dr. Block has reached a scale that is sustainable in the long term (although the charitable pharmacy 
comes closest to achieving that goal).  
Despite these limitations, much has been learned in this exploratory case study. 
This IT-focused hybrid social startup encountered many challenges, yet (similar to many entrepreneurs), 
Dr. Block seemed to draw energy from each challenge. And, similar to a case study of a much larger and 
longer-lived IT-enabled hybrid social enterprise (Richardson et al. 2014), our exploratory case study 
reveals that agile principles are enacted in this hybrid social enterprise – as can be seen in fast-learn 
experimentation with innovative business models, processes, and organizational structures and adoption 
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of agile IT tools and practices (such as open collaboration, open source tools, and a mandate to develop 
simple and interoperable platforms). Furthermore, we propose that our findings regarding this social 
entrepreneur’s ability to fluidly cycle between commercial and social logics (similar to Khan et al. 2018) 
point to a form of social/commercial agility that is unique to hybrid social enterprises.  
Like many commercial entrepreneurs, pharmacist-turned social entrepreneur Dr. Block had neither 
management training nor IT training; he is learning on the job. He has encountered some speed bumps 
on his journey thus far, and his charitable pharmacy continues to rely on grants and loans -- but to a 
lesser extent today than a few years ago, thanks to improved operational efficiency. This exploratory case 
study demonstrates that an IT-enabled hybrid social startup applies agile principles in ways that help 
resolve conflicting social and business goals. We urge AMCIS attendees to conduct further studies about 
IT-enabled hybrid social enterprises of various sizes and at various stages of maturity in a variety of 
societal and industrial contexts, via case studies and other research methods. 
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